FDA Approves New Epilepsy Drug
- Share via
WASHINGTON — The first new epilepsy drug in more than 10 years was approved by the Food and Drug Administration on Monday.
The drug, felbamate, will be prescribed to prevent partial seizures in adults. It was also approved for use to treat a rare form of epilepsy in children known as Lennox-Gastaut syndrome.
About 2.5 million Americans have epilepsy and 125,000 new patients are found to have the disease each year.
Wallace Laboratories of Cranbury, N.J., will market the new drug under the brand name Felbatol.
More From the Los Angeles Times
Podcasts
This episode examines what we know about what happened between the Lachman Fire and the Palisades Fire, and the missteps and miscommunication that may have led to one of California’s most destructive fires in history.
Marvin Margolis was a promising early suspect in the Black Dahlia murder, but he managed to slip through the cracks. So who was this man of many pseudonyms?
Not for want of trying – cleaner power has created lots of engine experiments, most dramatically Caltech versus MIT in the great electric car race of 1968, a story you’ll hear from the winner.
